Company Filing History:
Years Active: 2015
Title: Seung Yong Kim: Innovator in Cancer Treatment
Introduction
Seung Yong Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment.
Latest Patents
Seung Yong Kim holds a patent for a novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative. This patent includes a pharmaceutically acceptable salt, a preparation method, and a pharmaceutical composition with inhibitory activity against Raf kinase. The invention is particularly relevant for its potential use in preventing or treating various cancers, including melanoma, colorectal cancer, prostate cancer, thyroid cancer, and ovarian cancer. The purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative effectively regulates the activity of B-Raf kinase, which is crucial in the context of cancer treatment.
Career Highlights
Seung Yong Kim is currently associated with Medpacto Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for cancers that are driven by the over-activation of Raf kinase.
Collaborations
He collaborates with talented colleagues, including Eun Kyong Shim and Nam Doo Kim, who contribute to the research and development efforts at Medpacto Inc.
Conclusion
Seung Yong Kim's innovative work in cancer treatment exemplifies the impact of targeted pharmaceutical research. His contributions are paving the way for new therapeutic options in oncology.